As of the close of business on March 31, 2013, ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP), or the Company, had approximately ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE